Literature DB >> 34806400

Tetrahydrobiopterin in Cell Function and Death Mechanisms.

Jeannette Vasquez-Vivar1, Zhongjie Shi2, Sidhartha Tan2,3.   

Abstract

Significance: Tetrahydrobiopterin (BH4) is most well known as a required cofactor for enzymes regulating cellular redox homeostasis, aromatic amino acid metabolism, and neurotransmitter synthesis. Less well known are the effects dependent on the cofactor's availability, factors governing its synthesis and recycling, redox implications of the cofactor itself, and protein-protein interactions that underlie cell death. This review provides an understanding of the recent advances implicating BH4 in the mechanisms of cell death and suggestions of possible therapeutic interventions. Recent Advances: The levels of BH4 often reflect the sum of synthetic and recycling enzyme activities. Enhanced expression of GTP cyclohydrolase, the rate-limiting enzyme in biosynthesis, increases BH4, leading to improved cell function and survival. Pharmacologically increasing BH4 levels has similar beneficial effects, leading to enhanced production of neurotransmitters and nitric oxide or reducing oxidant levels. The GTP cyclohydrolase-BH4 pairing has been implicated in a type of cell death, ferroptosis. At the cellular level, BH4 counteracts anticancer therapies directed to enhance ferroptosis via glutathione peroxidase 4 (GPX4) activity inhibition. Critical Issues: Because of the multitude of intertwined mechanisms, a clear relationship between BH4 and cell death is not well understood yet. The possibility that the cofactor directly influences cell viability has not been excluded in previous studies when modulating BH4-producing enzymes. Future Directions: The importance of cellular BH4 variations and BH4 biosynthetic enzymes to cell function and viability makes it essential to better characterize temporal changes, cofactor activity, and the influence on redox status, which in turn would help develop novel therapies. Antioxid. Redox Signal. 37, 171-183.

Entities:  

Keywords:  apoptosis; ferroptosis; necroptosis; nitric oxide; oxidants; sepiapterin

Mesh:

Substances:

Year:  2022        PMID: 34806400      PMCID: PMC9293684          DOI: 10.1089/ars.2021.0136

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   7.468


  109 in total

1.  The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.

Authors:  Shane J F Cronin; Corey Seehus; Adelheid Weidinger; Sebastien Talbot; Sonja Reissig; Markus Seifert; Yann Pierson; Eileen McNeill; Maria Serena Longhi; Bruna Lenfers Turnes; Taras Kreslavsky; Melanie Kogler; David Hoffmann; Melita Ticevic; Débora da Luz Scheffer; Luigi Tortola; Domagoj Cikes; Alexander Jais; Manu Rangachari; Shuan Rao; Magdalena Paolino; Maria Novatchkova; Martin Aichinger; Lee Barrett; Alban Latremoliere; Gerald Wirnsberger; Guenther Lametschwandtner; Meinrad Busslinger; Stephen Zicha; Alexandra Latini; Simon C Robson; Ari Waisman; Nick Andrews; Michael Costigan; Keith M Channon; Guenter Weiss; Andrey V Kozlov; Mark Tebbe; Kai Johnsson; Clifford J Woolf; Josef M Penninger
Journal:  Nature       Date:  2018-11-07       Impact factor: 49.962

Review 2.  Nitric oxide synthase enzymology in the 20 years after the Nobel Prize.

Authors:  Dennis J Stuehr; Mohammad Mahfuzul Haque
Journal:  Br J Pharmacol       Date:  2018-12-09       Impact factor: 8.739

Review 3.  Mitochondria and Calcium in Alzheimer's Disease: From Cell Signaling to Neuronal Cell Death.

Authors:  Maria Calvo-Rodriguez; Brian J Bacskai
Journal:  Trends Neurosci       Date:  2020-11-04       Impact factor: 13.837

4.  Timing of appearance of late oligodendrocyte progenitors coincides with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia-ischemia.

Authors:  Joshua R Buser; Kristen N Segovia; Justin M Dean; Kerst Nelson; Douglas Beardsley; Xi Gong; Ning Ling Luo; Jennifer Ren; Ying Wan; Art Riddle; Melissa M McClure; Xinhai Ji; Matthew Derrick; A Roger Hohimer; Stephen A Back; Sidhartha Tan
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-13       Impact factor: 6.200

5.  Tetrahydrobiopterin in the prevention of hypertonia in hypoxic fetal brain.

Authors:  Jeannette Vásquez-Vivar; Jennifer Whitsett; Matthew Derrick; Xinhai Ji; Lei Yu; Sidhartha Tan
Journal:  Ann Neurol       Date:  2009-09       Impact factor: 10.422

6.  RIPK1 inhibitor ameliorates the MPP+/MPTP-induced Parkinson's disease through the ASK1/JNK signalling pathway.

Authors:  Jing Liu; Huizheng Hu; Binyan Wu
Journal:  Brain Res       Date:  2021-01-30       Impact factor: 3.252

7.  Nitric Oxide Modulates Metabolic Remodeling in Inflammatory Macrophages through TCA Cycle Regulation and Itaconate Accumulation.

Authors:  Jade D Bailey; Marina Diotallevi; Thomas Nicol; Eileen McNeill; Andrew Shaw; Surawee Chuaiphichai; Ashley Hale; Anna Starr; Manasi Nandi; Elena Stylianou; Helen McShane; Simon Davis; Roman Fischer; Benedikt M Kessler; James McCullagh; Keith M Channon; Mark J Crabtree
Journal:  Cell Rep       Date:  2019-07-02       Impact factor: 9.423

8.  Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson's disease.

Authors:  Pedro A Dionísio; Sara R Oliveira; Maria M Gaspar; Maria J Gama; Margarida Castro-Caldas; Joana D Amaral; Cecilia M P Rodrigues
Journal:  Cell Death Dis       Date:  2019-11-05       Impact factor: 8.469

9.  Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.

Authors:  N Takahashi; L Duprez; S Grootjans; A Cauwels; W Nerinckx; J B DuHadaway; V Goossens; R Roelandt; F Van Hauwermeiren; C Libert; W Declercq; N Callewaert; G C Prendergast; A Degterev; J Yuan; P Vandenabeele
Journal:  Cell Death Dis       Date:  2012-11-29       Impact factor: 8.469

10.  Neuroprotective effects of DAHP and Triptolide in focal cerebral ischemia via apoptosis inhibition and PI3K/Akt/mTOR pathway activation.

Authors:  Weiyun Li; Yang Yang; Zhiying Hu; Shucai Ling; Marong Fang
Journal:  Front Neuroanat       Date:  2015-04-22       Impact factor: 3.856

View more
  3 in total

1.  The Role of ANGPTL Gene Family Members in Hepatocellular Carcinoma.

Authors:  Yun Bai; Dan Lu; Di Qu; Yiwen Li; Ning Zhao; Guanghua Cui; Xue Li; Xiaoke Sun; Yanying Liu; Meiqi Wei; Yu Yang
Journal:  Dis Markers       Date:  2022-06-01       Impact factor: 3.464

2.  Posttreatment Recurrence and Death Patterns in Patients with Advanced Esophageal Cancer.

Authors:  Xiangmei Zhang; Hui Wang; Dongwei He; Ming He; Xin Chen; Jidong Zhao
Journal:  Dis Markers       Date:  2022-07-09       Impact factor: 3.464

3.  The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients.

Authors:  Zhining Liu; Yimei Gu; Fulong Yu; Lianbang Zhou; Xiaohu Cheng; Heng Jiang; Yang Huang; Yingfeng Zhang; Tongtong Xu; Wenbao Qian; Xianghua Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-23       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.